Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael A Blazing

Showing results (1-10 of 70) with videos related to

Pageof 7
Sort By:
Current Treatment Options in Cardiovascular Medicine|August 28, 2013
Inflammation and atherosclerosis: disease modulating therapiesMahesh J Patel, Michael A Blazing
American Heart Journal|August 30, 2003
Enhanced External Counterpulsation (EECP): enough evidence to support this and the next wave?Michael A Blazing, Lawrence E Crawford
The New England Journal of Medicine|October 8, 2015
Ezetimibe plus a Statin after Acute Coronary SyndromesChristopher P Cannon, Michael A Blazing, Eugene Braunwald
Circulation|September 11, 2023
Why Novel Therapies in Preventive Cardiology May Face a Marathon, Not a SprintJoanna S Cavalier, Nishant P Shah, Michael A Blazing
JAMA Cardiology|January 3, 2020
Interpreting the Benefit of Simvastatin-Ezetimibe in Patients 75 Years or Older-ReplyRichard G Bach, Christopher P Cannon, Michael A Blazing
The New England Journal of Medicine|August 14, 2009
Premature release of data from clinical trials of ezetimibeRobert M Califf, Robert A Harrington, Michael A Blazing
Journal of Cardiovascular Risk|December 13, 2002
Targeting cardiovascular risk associated with both low density and high density lipoproteins using statin-niacin combination therapyW Lane Duvall, Michael A Blazing, Shilpa Saxena, et al.
The American Journal of Cardiology|June 15, 2004
Efficacy and safety of ezetimibe co-administered with simvastatin compared with atorvastatin in adults with hypercholesterolemiaChristie M Ballantyne, Michael A Blazing, Thomas R King, et al.
Chest|January 16, 2007
Small cell lung cancer presenting as a paraneoplastic syndrome characterized by recurrent episodic hypotension and bradycardia: case reportMike G Martin, Amer K Ardati, Shannon M Dunlay, et al.
Circulation. Heart Failure|January 18, 2022
Unexplained Dyspnea on Exertion: The Difference the Right Test Can MakeVishal N Rao, Michelle D Kelsey, Michael A Blazing, et al.
Pageof 7

Showing results (1-10 of 70) with videos related to

Sort By:
Pageof 7
Current Treatment Options in Cardiovascular Medicine|August 28, 2013
Inflammation and atherosclerosis: disease modulating therapiesMahesh J Patel, Michael A Blazing
American Heart Journal|August 30, 2003
Enhanced External Counterpulsation (EECP): enough evidence to support this and the next wave?Michael A Blazing, Lawrence E Crawford
The New England Journal of Medicine|October 8, 2015
Ezetimibe plus a Statin after Acute Coronary SyndromesChristopher P Cannon, Michael A Blazing, Eugene Braunwald
Circulation|September 11, 2023
Why Novel Therapies in Preventive Cardiology May Face a Marathon, Not a SprintJoanna S Cavalier, Nishant P Shah, Michael A Blazing
JAMA Cardiology|January 3, 2020
Interpreting the Benefit of Simvastatin-Ezetimibe in Patients 75 Years or Older-ReplyRichard G Bach, Christopher P Cannon, Michael A Blazing
The New England Journal of Medicine|August 14, 2009
Premature release of data from clinical trials of ezetimibeRobert M Califf, Robert A Harrington, Michael A Blazing
Journal of Cardiovascular Risk|December 13, 2002
Targeting cardiovascular risk associated with both low density and high density lipoproteins using statin-niacin combination therapyW Lane Duvall, Michael A Blazing, Shilpa Saxena, et al.
The American Journal of Cardiology|June 15, 2004
Efficacy and safety of ezetimibe co-administered with simvastatin compared with atorvastatin in adults with hypercholesterolemiaChristie M Ballantyne, Michael A Blazing, Thomas R King, et al.
Chest|January 16, 2007
Small cell lung cancer presenting as a paraneoplastic syndrome characterized by recurrent episodic hypotension and bradycardia: case reportMike G Martin, Amer K Ardati, Shannon M Dunlay, et al.
Circulation. Heart Failure|January 18, 2022
Unexplained Dyspnea on Exertion: The Difference the Right Test Can MakeVishal N Rao, Michelle D Kelsey, Michael A Blazing, et al.
Pageof 7